|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
US4777127A
(en)
|
1985-09-30 |
1988-10-11 |
Labsystems Oy |
Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US4704692A
(en)
|
1986-09-02 |
1987-11-03 |
Ladner Robert C |
Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
|
|
IL85035A0
(en)
|
1987-01-08 |
1988-06-30 |
Int Genetic Eng |
Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
|
|
GB8702816D0
(en)
|
1987-02-07 |
1987-03-11 |
Al Sumidaie A M K |
Obtaining retrovirus-containing fraction
|
|
US5219740A
(en)
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
|
US5422120A
(en)
|
1988-05-30 |
1995-06-06 |
Depotech Corporation |
Heterovesicular liposomes
|
|
AP129A
(en)
|
1988-06-03 |
1991-04-17 |
Smithkline Biologicals S A |
Expression of retrovirus gag protein eukaryotic cells
|
|
JP2752788B2
(ja)
|
1989-01-23 |
1998-05-18 |
カイロン コーポレイション |
感染および過剰増殖障害の為の組換え療法
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
ES2116269T3
(es)
|
1989-03-21 |
1998-07-16 |
Vical Inc |
Expresion de secuencias exogenas de polinucleotidos en un vertebrado.
|
|
JP4041535B2
(ja)
|
1989-08-18 |
2008-01-30 |
オックスフォード バイオメディカ（ユーケー）リミテッド |
標的細胞にベクター構造体を運搬する組換レトロウィルス
|
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
ZA911974B
(en)
|
1990-03-21 |
1994-08-22 |
Res Dev Foundation |
Heterovesicular liposomes
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
JP3534749B2
(ja)
|
1991-08-20 |
2004-06-07 |
アメリカ合衆国 |
アデノウイルスが介在する胃腸管への遺伝子の輸送
|
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
|
WO1993010218A1
(en)
|
1991-11-14 |
1993-05-27 |
The United States Government As Represented By The Secretary Of The Department Of Health And Human Services |
Vectors including foreign genes and negative selective markers
|
|
GB9125623D0
(en)
|
1991-12-02 |
1992-01-29 |
Dynal As |
Cell modification
|
|
FR2688514A1
(fr)
|
1992-03-16 |
1993-09-17 |
Centre Nat Rech Scient |
Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
|
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
EP0650370A4
(en)
|
1992-06-08 |
1995-11-22 |
Univ California |
METHODS AND COMPOSITIONS TARGETED ON SPECIFIC TISSUES.
|
|
CA2137361A1
(en)
|
1992-06-10 |
1993-12-23 |
W. French Anderson |
Vector particles resistant to inactivation by human serum
|
|
GB2269175A
(en)
|
1992-07-31 |
1994-02-02 |
Imperial College |
Retroviral vectors
|
|
AU680459B2
(en)
|
1992-12-03 |
1997-07-31 |
Genzyme Corporation |
Gene therapy for cystic fibrosis
|
|
US5981568A
(en)
|
1993-01-28 |
1999-11-09 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
PT695169E
(pt)
|
1993-04-22 |
2003-04-30 |
Skyepharma Inc |
Lipossomas multivesiculares de ciclodextrina encapsulando compostos farmacologicos e metodos para a sua utilizacao
|
|
ES2249761T3
(es)
|
1993-06-24 |
2006-04-01 |
Advec Inc. |
Vectores de adenovirus para terapia genica.
|
|
US6015686A
(en)
|
1993-09-15 |
2000-01-18 |
Chiron Viagene, Inc. |
Eukaryotic layered vector initiation systems
|
|
ES2328424T3
(es)
|
1993-09-15 |
2009-11-12 |
Novartis Vaccines And Diagnostics, Inc. |
Vectores de alfavirus recombinantes.
|
|
EP1637608B1
(en)
|
1993-10-25 |
2009-07-22 |
CANJI, Inc. |
Recombinant adenoviral vector and methods of use
|
|
PT729351E
(pt)
|
1993-11-16 |
2000-12-29 |
Skyepharma Inc |
Vesiculas com libertacao controlada de activos
|
|
WO1995030763A2
(en)
|
1994-05-09 |
1995-11-16 |
Chiron Viagene, Inc. |
Retroviral vectors having a reduced recombination rate
|
|
AU4594996A
(en)
|
1994-11-30 |
1996-06-19 |
Chiron Viagene, Inc. |
Recombinant alphavirus vectors
|
|
US6265150B1
(en)
|
1995-06-07 |
2001-07-24 |
Becton Dickinson & Company |
Phage antibodies
|
|
WO1997042338A1
(en)
|
1996-05-06 |
1997-11-13 |
Chiron Corporation |
Crossless retroviral vectors
|
|
US6824995B1
(en)
*
|
1998-03-03 |
2004-11-30 |
Emory University |
Diagnostic for metastatic prostate cancer
|
|
GB9809951D0
(en)
|
1998-05-08 |
1998-07-08 |
Univ Cambridge Tech |
Binding molecules
|
|
EP1158997A2
(en)
|
1999-03-09 |
2001-12-05 |
University Of Southern California |
Method of promoting myocyte proliferation and myocardial tissue repair
|
|
CA2471849A1
(en)
|
2001-12-28 |
2003-07-17 |
Abgenix, Inc. |
Antibodies against the muc18 antigen
|
|
EP1467756A4
(en)
|
2001-12-28 |
2007-03-21 |
Abgenix Inc |
METHODS OF USING ANTI-MUC18 ANTIBODIES
|
|
KR101672271B1
(ko)
|
2007-12-18 |
2016-11-03 |
바이오얼라이언스 씨.브이. |
암세포에서 발현된 ｃｄ-43 및 ｃｅａ 상의 탄수화물 함유 에피토프를 인식하는 항체 및 그것의 사용 방법
|
|
CN101245101B
(zh)
*
|
2008-01-31 |
2013-10-16 |
中国科学院生物物理研究所 |
抗人cd146的单克隆抗体，包含其的组合物，检测可溶性cd146的方法
|
|
EP2430051B1
(en)
*
|
2009-05-14 |
2016-03-23 |
Institut National de la Santé et de la Recherche Medicale |
Compositions containing antibodies for treating cd5+ hla-dr+ b or t cell related diseases
|
|
US9676871B2
(en)
|
2010-11-05 |
2017-06-13 |
Pfizer Inc. |
Engineered polypeptide conjugates and methods for making thereof using transglutaminase
|
|
WO2013143026A1
(en)
|
2012-03-31 |
2013-10-03 |
Abmart (Shanghai) Co., Ltd |
Peptide and antibody libraries and uses thereof
|
|
TWI660972B
(zh)
|
2012-09-10 |
2019-06-01 |
愛爾蘭商尼歐托普生物科學公司 |
抗ｍｃａｍ抗體及相關使用方法
|
|
WO2015044218A1
(en)
*
|
2013-09-24 |
2015-04-02 |
Oncoinvent As |
Monoclonal antibody and derivatives
|
|
PT3116911T
(pt)
|
2014-03-12 |
2019-09-04 |
Prothena Biosciences Ltd |
Anticorpos anti-mcam e métodos de utilização associados
|
|
CN104650231A
(zh)
|
2015-02-13 |
2015-05-27 |
南京任诺药业有限公司 |
一种具备高效中和活性的人源化抗人cd146单克隆抗体
|
|
WO2017046776A2
(en)
*
|
2015-09-16 |
2017-03-23 |
Prothena Biosciences Limited |
Use of anti-mcam antibodies for treatment or prophylaxis of giant cell arteritis, polymyalgia rheumatica or takayasu's arteritis
|
|
WO2017149513A1
(en)
|
2016-03-03 |
2017-09-08 |
Prothena Biosciences Limited |
Anti-mcam antibodies and associated methods of use
|
|
US20190192573A1
(en)
*
|
2016-08-19 |
2019-06-27 |
Oncoinvent As |
Anti-osteosarcoma car-t derived from the antibody oi-3
|
|
WO2018220467A1
(en)
*
|
2017-05-30 |
2018-12-06 |
Foroogh Nejatollahi |
Anti-muc18 human immunotoxin and applications thereof
|
|
CN108129567B
(zh)
*
|
2018-01-09 |
2019-02-26 |
南京任诺药业有限公司 |
一种具备高效中和活性的人源化抗人cd146单克隆抗体
|
|
CN117343187A
(zh)
|
2018-12-21 |
2024-01-05 |
普众发现医药科技(上海)有限公司 |
对muc18特异性的抗体
|